PLEXXIKON
Plexxikon, Inc. engages in the discovery and development of small molecule pharmaceuticals to treat human disease. The company's products include PLX204 for the treatment of diabetes; PLX4032 for the treatment of melanoma and colorectal cancer; and PLX5568 kinase inhibitors for the treatment of pain, polycystic kidney disease, rheumatoid arthritis, metastatic breast cancer, and renal disease. It develops a portfolio of clinical and preclinical stage programs in various therapeutic areas,... including metabolic disease, such as obesity indications; oncology, such as osteolytic metastatic disease; and CNS, such as multiple sclerosis. The company’s portfolio of clinical and preclinical stage programs for other therapeutic areas include inflammation, such as systemic lupus erythematosus, inflammatory bowel disease, and osteoporosis; and cardiovascular, including hypertension and atherosclerosis.
PLEXXIKON
Social Links:
Industry:
Biotechnology Health Care Medical
Founded:
2000-01-01
Address:
Berkeley, California, United States
Country:
United States
Website Url:
http://www.plexxikon.com
Total Employee:
51+
Status:
Active
Contact:
(510)548-8014
Email Addresses:
[email protected]
Total Funding:
80.35 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics Google Universal Analytics DigiCert SSL ATT
Similar Organizations
Fedora Pharmaceuticals
Fedora Pharmaceuticals engages in the discovery and development of antibiotics for life-threatening microbial drug resistance needs.
Knopp Biosciences
Knopp Neurosciences is a drug discovery and development company working on treatments for neurological disorders.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
TorreyPines Therapeutics
TorreyPines Therapeutics engages in the discovery and development of small molecule compounds in the United States.
Current Advisors List
Current Employees Featured
Founder
Investors List
Alta Partners
Alta Partners investment in Series B - Plexxikon
A. M. Pappas & Associates
A. M. Pappas & Associates investment in Series B - Plexxikon
NIF Ventures
NIF Ventures investment in Series B - Plexxikon
CW Ventures
CW Ventures investment in Series B - Plexxikon
Gimv
Gimv investment in Series B - Plexxikon
Advanced Technology Ventures
Advanced Technology Ventures investment in Series B - Plexxikon
Walden International
Walden International investment in Series B - Plexxikon
